Ventyx Biosciences Newsroom

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx"), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of

GlobeNewswireMay 16 16:05 ET

Express News | Ventyx Biosciences Shares Are Trading Higher. The Company Appointed Matthew Moore as COO

BenzingaMay 16 10:55 ET

Ventyx Biosciences Gets New Operations Chief

Seeking AlphaMay 16 08:36 ET

Express News | Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer

ReutersMay 16 08:00 ET

Press Release: Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer

Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), ("Ventyx"), a clinical-stage

Dow JonesMay 16 08:00 ET

Stifel Nicolaus Keeps Their Hold Rating on Ventyx Biosciences (VTYX)

TipRanksMay 15 22:05 ET

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 13 10:37 ET

Analysts Offer Insights on Healthcare Companies: Quantum-Si (QSI), Savara (SVRA) and Ventyx Biosciences (VTYX)

TipRanksMay 13 07:00 ET

Ventyx Biosciences (VTYX) Receives a Buy From Oppenheimer

TipRanksMay 10 07:58 ET

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Incyte (INCY) and Ventyx Biosciences (VTYX)

TipRanksMay 10 07:30 ET

Ventyx Biosciences: A Prudent Hold Amidst Promising Drug Potential and Market Uncertainties

TipRanksMay 10 06:28 ET

Buy Rating for Ventyx Biosciences Based on Clinical and Financial Strengths

TipRanksMay 10 05:59 ET

Express News | Ventyx Biosciences Inc - Qtrly Net Loss $38.6 Mln

ReutersMay 9 16:54 ET

Ventyx Biosciences | 10-Q: Quarterly report

Futu NewsMay 9 16:27 ET · Announcements

Express News | Ventyx Biosciences: Cash, Cash Equivalents & Marketable Securities as of March 31, 2024 Expected to Fund Planned Operations Into at Least H2of 2026

ReutersMay 9 16:20 ET

Express News | Ventyx Biosciences Q1 2024 GAAP EPS $(0.62) Beats $(0.67) Estimate

BenzingaMay 9 16:02 ET

Ventyx Biosciences 1Q Loss $38.6M >VTYX

Ventyx Biosciences 1Q Loss $38.6M >VTYX

Dow JonesMay 9 16:02 ET

Express News | Ventyx Biosciences Q1 Operating Expenses USD 41.768 Million

ReutersMay 9 16:01 ET

Express News | Ventyx Biosciences Q1 Net Income USD -38.572 Million Vs. Ibes Estimate USD -41.2 Million

ReutersMay 9 16:01 ET

Express News | Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress

ReutersMay 9 16:01 ET